Artificial Tears

Healio’s top ophthalmic business-related items in 2023 covered the changing landscape of determining prices for drugs in the U.S. and the recall of generic artificial tears.

Oh my. Another FDA recall of generic artificial tears hit the news during eyeball month.

NEW ORLEANS — Nearly 90% of dry eye disease specialists surveyed use artificial tears and hot compresses as first-line treatment for meibomian gland dysfunction, according to a poster presented at Academy ’23.

Ten years ago, we had one or two options for preservative-free artificial tears, and they were expensive and hard to find.

Healio spoke with I. Paul Singh, MD, about risk factors for developing dry eye, particularly in women.

In this video, Ronald L. Benner, OD, discusses exciting new research in dry eye.

In this video, Ronald L. Benner, OD, discusses treatment options in dry eye.

The CDC announced that 68 patients in 16 states have been identified as of March 21 with a drug-resistant strain of Pseudomonas aeruginosa believed to have originated in multidose bottles of artificial tears.

The CDC issued a statement recommending that clinicians and patients discontinue using EzriCare Artificial Tears due a possible link to eye infections that have led to vision loss, hospitalization and death.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Lisa M. Nijm, MD, JD, discusses the importance of artificial tears in patients with systemic diseases who have chronic dry eye.